(In the Media) “Study group for the suitable drug information” recommended pharmaceutical industry (the Nikkei Medical, the July 2016 edition)
date : 7/1/2016
An article featuring a “Round-table discussion among those with ‘Study group for the suitable drug information’ recommended pharmaceutical industry.’ in which Toshio Miyata, HGPI Board Member participated, appeared in the July 2016 edition of the Nikkei Medical.
This study group is organized by Nikkei Medical and the member are 5 are doctors. They take more regulation of providing drug information seriously.
In the last four meetings, they were talking about desirable drug information. And this time, they recommended the suitable drug information for the pharmaceutical industry.
Top Research & Recommendations Posts
Featured Posts
-
2026-08-28
[Announcement] The 3rd Kiyoshi Kurokawa Award: Call for Nominations (Deadline: November 30, 2026)
-
2026-11-05
[Registration Open] HGPI Salon 2025-2026 Looking Ahead to the Future of Japan’s Social Security System “Session 7: Where We’ve Been and Where We’re Going: Lessons from Pandemic Response” (December 18, 2026)
-
2026-11-13
[Discussion Points] Addressing AMR Measures for an Era of Healthy Longevity: Ensuring Safety and Security for Older Adults in a Super-Aged Society (October 23, 2026)



